This session will focus on the fundamentals of digital health. Covid certainly seems to have proven to be a much needed inflexion point for the recognition and adoption of digital health more widely - the genie is out of the bottle! With that as an anchor, the session will hone in on digital therapeutics (DTx) as a key value driver in the industry - what DTx constitutes, clinical evidence requirements, commercialization approaches, regulatory frameworks, etc.

Lessons learned from success and failures, and gaze a little bit into the future of virtual care delivery.